Opioid over-dose and death continues to be on the rise across Canada. As a result, each province has created a strategy to address the opioid crisis. Pharmacist distribution of naloxone kits are a part of that strategy, but in various ways across the country.
Ordering Naloxone Kits
In Saskatchewan, some health regions are providing naloxone kits at no charge for patients. See Take Home Naloxone: Site Locations for a list of regions offering the kits at no charge. There is the PAS Naloxone Registry which lists the pharmacies carrying naloxone kits.
Pharmacies may purchase kits from Mckesson Canada or a company calls the Control Group. Kits may be sold to patients or their caregivers.
Mckesson Canada: Item # 114569 (no minimum order).
The Control Group: Use this order form to purchase kits (no minimum order).
At this time, no government funded fee is in place for counseling on the use of the kits. However, since naloxone is a Schedule II drug the pharmacist must be involved in the sale of naloxone, which includes arriving at the decision to sell the drug and counseling patients or their caregiver appropriately.
Ordering Narcan Nasal Spray
Narcan Nasal Spray (Naloxone Hcl) 4mg
Minimum order is 2 packs (Orders less than the 12 minimum require credit card payment)
Send a purchase order or an email with the below information to process the order:
- Bill to address
- Ship to address
- Buyers name and telephone number
- Accounts payable contact and number
Payable by cheque/EFT or credit card to:
Adapt Pharma Canada Ltd
P.O. Box 56231, STN A
Toronto, ON M5W 4L1
Shipping time for Saskatchewan: 3-4 business days
Click here for more information about Narcan
Education and Support
CPhA has created some excellent resources and tools about naloxone for pharmacists available on their website at:
Infographic for Patients: a sheet that can be printed off and provided to patients about the signs and symptoms of an opioid overdose and how to inject naloxone.
Naloxone Injection Video: a short video intended for the person who may need to administer naloxone, but that might not familiar with how to administer it.
Naloxone Nasal Spray Video: a short video on how to use the naloxone nasal spray
Naloxone for Opioid Overdose: What Pharmacists Need to Know an excellent recorded webinar for pharmacists about opioid overdose, the therapeutics of and how to counsel on administering naloxone.
Environmental Scan of Naloxone Access: a national report on the access to naloxone in Canada.
Saskatchewan Ministry of Health Resources
This checklist assesses the understanding and knowledge of the individual receiving information about naloxone and its administration.
This manual that will assist you in educating individuals about overdose prevention and response. This manual includes education about the use of naloxone, an opioid antidote, to address the morbidity and mortality associated with opioid overdoses.
Opioid Overdose and Take Home Naloxone This is presented by CPDPP by Katy Windl
Navigating Opioids for Chronic Pain Infographic This is a patient resource that shows the rates of complications based on opioid dosage.
Opioid Wallet Cards These are available to order from the Health Canada website.
The 2019 PAS Membership and Malpractice Renewal is now open. PAS sent out an email last week to members on how they can renew their PAS membership.More
An Aging Population, Health care and the Role of Pharmacists in Saskatchewan with a National Comparison
The Pharmacy Association of Saskatchewan, in partnership with CPhA, commissions yearly public opinion surveys on public perceptions and attitudes towards pharmacists in Saskatchewan and across Canada.More
Update on EpiPen® Availability
There is a recent update from Pfizer Canada on EpiPen® and EpiPen Jr® auto-injectors.More
Joint CPhA/APhA Statement - Drug Importation Policy
The American Pharmacists Association (APhA) and the Canadian Pharmacists Association (CPhA) have issued a joint statement opposing U.S. federal legislation authorizing personal and commercial importation of prescription drugs from Canada.More